454 related articles for article (PubMed ID: 28872461)
1. Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis.
Wei Y; Kim TJ; Peng DH; Duan D; Gibbons DL; Yamauchi M; Jackson JR; Le Saux CJ; Calhoun C; Peters J; Derynck R; Backes BJ; Chapman HA
J Clin Invest; 2017 Oct; 127(10):3675-3688. PubMed ID: 28872461
[TBL] [Abstract][Full Text] [Related]
2. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor.
Park SJ; Choi YS; Lee S; Lee YJ; Hong S; Han S; Kim BC
Cancer Lett; 2016 Oct; 381(2):314-22. PubMed ID: 27543359
[TBL] [Abstract][Full Text] [Related]
3. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
[TBL] [Abstract][Full Text] [Related]
4. Kinase inhibitors fail to induce mesenchymal-epithelial transition in fibroblasts from fibrotic lung tissue.
Xu X; Wan X; Geng J; Li F; Wang C; Dai H
Int J Mol Med; 2013 Aug; 32(2):430-8. PubMed ID: 23760654
[TBL] [Abstract][Full Text] [Related]
5. Identification of TGF-β receptor-1 as a key regulator of carbon nanotube-induced fibrogenesis.
Mishra A; Stueckle TA; Mercer RR; Derk R; Rojanasakul Y; Castranova V; Wang L
Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L821-33. PubMed ID: 26472812
[TBL] [Abstract][Full Text] [Related]
6. The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis.
Liang C; Li X; Zhang L; Cui D; Quan X; Yang W
Exp Mol Pathol; 2015 Oct; 99(2):279-85. PubMed ID: 26216407
[TBL] [Abstract][Full Text] [Related]
7. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization.
Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH
Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
9. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-98 inhibits TGF-β1-induced differentiation and collagen production of cardiac fibroblasts by targeting TGFBR1.
Cheng R; Dang R; Zhou Y; Ding M; Hua H
Hum Cell; 2017 Jul; 30(3):192-200. PubMed ID: 28251559
[TBL] [Abstract][Full Text] [Related]
11. miR-1343 attenuates pathways of fibrosis by targeting the TGF-β receptors.
Stolzenburg LR; Wachtel S; Dang H; Harris A
Biochem J; 2016 Feb; 473(3):245-56. PubMed ID: 26542979
[TBL] [Abstract][Full Text] [Related]
12. A Small Dibromotyrosine Derivative Purified From Pseudoceratina Sp. Suppresses TGF-β Responsiveness by Inhibiting TGF-β Type I Receptor Serine/Threonine Kinase Activity.
Chen CL; Kao YC; Yang PH; Sung PJ; Wen ZH; Chen JJ; Huang YB; Chen PY
J Cell Biochem; 2016 Dec; 117(12):2800-2814. PubMed ID: 27153151
[TBL] [Abstract][Full Text] [Related]
13. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice.
Doi S; Zou Y; Togao O; Pastor JV; John GB; Wang L; Shiizaki K; Gotschall R; Schiavi S; Yorioka N; Takahashi M; Boothman DA; Kuro-O M
J Biol Chem; 2011 Mar; 286(10):8655-8665. PubMed ID: 21209102
[TBL] [Abstract][Full Text] [Related]
14. Augmenter of liver regeneration inhibits TGF-β1-induced renal tubular epithelial-to-mesenchymal transition via suppressing TβR II expression in vitro.
Liao XH; Zhang L; Chen GT; Yan RY; Sun H; Guo H; Liu Q
Exp Cell Res; 2014 Oct; 327(2):287-96. PubMed ID: 25092350
[TBL] [Abstract][Full Text] [Related]
15. The matricellular protein CCN1 enhances TGF-β1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury.
Kurundkar AR; Kurundkar D; Rangarajan S; Locy ML; Zhou Y; Liu RM; Zmijewski J; Thannickal VJ
FASEB J; 2016 Jun; 30(6):2135-50. PubMed ID: 26884454
[TBL] [Abstract][Full Text] [Related]
16. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
Pan R; Zhang Y; Zang B; Tan L; Jin M
J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis.
Koh RY; Lim CL; Uhal BD; Abdullah M; Vidyadaran S; Ho CC; Seow HF
Mol Med Rep; 2015 May; 11(5):3808-13. PubMed ID: 25585520
[TBL] [Abstract][Full Text] [Related]
18. Significance of nuclear LOXL2 inhibition in fibroblasts and myofibroblasts in the fibrotic process of acute respiratory distress syndrome.
Matsuo A; Tanida R; Yanagi S; Tsubouchi H; Miura A; Shigekusa T; Matsumoto N; Nakazato M
Eur J Pharmacol; 2021 Feb; 892():173754. PubMed ID: 33248114
[TBL] [Abstract][Full Text] [Related]
19. LOXL2, a copper-dependent monoamine oxidase, activates lung fibroblasts through the TGF-β/Smad pathway.
Wen X; Liu Y; Bai Y; Li M; Fu Q; Zheng Y
Int J Mol Med; 2018 Dec; 42(6):3530-3541. PubMed ID: 30320382
[TBL] [Abstract][Full Text] [Related]
20. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.
Fujiwara A; Shintani Y; Funaki S; Kawamura T; Kimura T; Minami M; Okumura M
Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]